Filing Details

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THEREOF FILED PURSUANT TO § 240.13d-2

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*

 

DarioHealth Corp.

(Name of Issuer)

 

Shares of Common Stock

(Title of Class of Securities)

 

23725P100, 23725P118

 

(CUSIP Number)

 

April 12, 2017

 

 (Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨

Rule 13d-1(b)

 

x

Rule 13d-1(c)

 

¨

Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 23725P100; 23725P118

13G

Page 2 of 6 Pages

  

1.	Names of Reporting Persons   Ben Farhi
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (See Instructions) (a) ¨ (b) ¨
3.	SEC Use Only
4.	Citizenship or Place of Organization   Canadian

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	Sole Voting Power   213,334 (1)
	6.	Shared Voting Power   0
	7.	Sole Dispositive Power   213,334 (1)
	8.	Shared Dispositive Power   0

9.	Aggregate Amount Beneficially Owned by Each Reporting Person   213,334 (1)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

¨

11.	Percent of Class Represented by Amount in Row (9)   2.0%
12.	Type of Reporting Person (See Instructions)   IN

 

(1)       Reflects sole voting / dispositive power as of October 5, 2017. Includes 213,334 warrants to purchase common stock issued to the Reporting Person.

 

 

CUSIP No. 23725P100; 23725P118

13G

Page 3 of 6 Pages

 

Item 1(a).

Name of Issuer:

 

DarioHealth Corp.

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

 

9 Halamish Street, Caesarea Industrial Park, 3088900, Israel

 

Item 2(a).

Name of Person Filing:

 

This Statement is filed on behalf of Ben Farhi (the “Reporting Person”).

 

Item 2(b).

Address of Principal Offices or, if None, Residence:

 

The address of the Reporting Person is:

 

90 St. Bees St., London, Ontario, Canada

 

Item 2(c).

Citizenship:

 

Ben Farhi is a Canadian citizen.

 

Item 2(d).

Title of Class of Securities:

 

Shares of Common Stock

 

Item 2(e).

CUSIP Number:

 

23725P100; 23725P118

 

Item 3.

If the Statement is being filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the filing person is a:

 

Not applicable.

 

(a)	¨	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	¨	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	¨	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	¨	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	¨	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)	¨	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)	¨	A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)	¨	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	¨	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
(j)	¨	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
(k)	¨	Group, in accordance with §240.13d-1(b)(1)(ii)(K).

 

 

 

CUSIP No. 23725P100; 23725P118

13G

Page 4 of 6 Pages

 

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:__________________________________________________________________________

 

Item 4.

Ownership.

 

(a)   Amount beneficially owned: 213,334 shares of Common Stock (consisting of (i) No shares of common stock held by the Reporting Person as of October 5, 2017, and (ii) 213,334 warrants to purchase common stock issued to the Reporting Person as of October 5, 2017.

 

(b)

Percent of class:

 

2.0%

 

(c)

Number of shares as to which such person has:

 

(i)

Sole power to vote or direct the vote: 213,334

 

(ii)

Shared power to vote or direct the vote: 0

 

(iii)

Sole power to dispose or to direct the disposition of: 213,334

 

(iv)

Shared power to dispose or to direct the disposition of: 0

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person had ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X].

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.

Notice of Dissolution of Group.

 

Not applicable.

 

Item 10.

Certification.

 

(a)   Not applicable.

 

(b)   Not applicable.

 

 

CUSIP No. 23725P100; 23725P118

13G

Page 5 of 6 Pages

 

(c)   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

CUSIP No. 23725P100; 23725P118

13G

Page 6 of 6 Pages

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	October 10, 2017
	(Date)
	/s/ Ben Farhi
	(Signature)

 

Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).